BIOCRYST PHARMACEUTICALS INC short interest in 2024
In 2024, BIOCRYST PHARMACEUTICALS INC's disclosed short interest ran from 13.70% of shares outstanding on 12 Jan 2024 to 7.59% on 31 Dec 2024, a change of -6.11 percentage points. The year's high was 17.53% on 31 May 2024 and its low 7.59% on 31 Dec 2024, averaging 12.56% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.50 days on 13 Sep 2024. Full history: BIOCRYST PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 13.70% (12 Jan 2024)
- End of year
- 7.59% (31 Dec 2024)
- Change
- -6.11 pp
- High
- 17.53% (31 May 2024)
- Low
- 7.59% (31 Dec 2024)
- Average
- 12.56%
- Highest days to cover
- 15.50 (13 Sep 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 13.70% | 5.86 | results (8-K) |
| 31 Jan 2024 | 14.18% | 11.59 | |
| 15 Feb 2024 | 14.36% | 9.20 | |
| 29 Feb 2024 | 14.21% | 10.13 | results (8-K), 10-K filed |
| 15 Mar 2024 | 14.91% | 8.74 | |
| 28 Mar 2024 | 15.75% | 10.10 | |
| 15 Apr 2024 | 16.79% | 11.42 | |
| 30 Apr 2024 | 16.30% | 10.46 | |
| 15 May 2024 | 16.65% | 7.26 | results (8-K), 10-Q filed |
| 31 May 2024 | 17.53% | 9.72 | |
| 14 Jun 2024 | 14.38% | 9.99 | |
| 28 Jun 2024 | 8.66% | 4.03 | |
| 15 Jul 2024 | 10.57% | 8.13 | |
| 31 Jul 2024 | 11.79% | 9.76 | |
| 15 Aug 2024 | 11.99% | 8.64 | results (8-K), 10-Q filed |
| 30 Aug 2024 | 11.63% | 13.53 | |
| 13 Sep 2024 | 11.76% | 15.50 | |
| 30 Sep 2024 | 11.23% | 11.67 | |
| 15 Oct 2024 | 10.89% | 15.04 | |
| 31 Oct 2024 | 10.06% | 13.40 | |
| 15 Nov 2024 | 8.93% | 5.85 | results (8-K), 10-Q filed |
| 29 Nov 2024 | 9.35% | 11.08 | |
| 13 Dec 2024 | 8.35% | 10.20 | |
| 31 Dec 2024 | 7.59% | 8.38 |
See also: BIOCRYST PHARMACEUTICALS INC's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.